GR3021440T3 - Therapeutic benzazepine compounds - Google Patents

Therapeutic benzazepine compounds

Info

Publication number
GR3021440T3
GR3021440T3 GR960402536T GR960402536T GR3021440T3 GR 3021440 T3 GR3021440 T3 GR 3021440T3 GR 960402536 T GR960402536 T GR 960402536T GR 960402536 T GR960402536 T GR 960402536T GR 3021440 T3 GR3021440 T3 GR 3021440T3
Authority
GR
Greece
Prior art keywords
treatment
therapeutic
formula
neurological disorders
benzazepine compounds
Prior art date
Application number
GR960402536T
Other languages
English (en)
Inventor
Marc Jerome Chapdelaine
Charles David Mclaren
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of GR3021440T3 publication Critical patent/GR3021440T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
GR960402536T 1991-01-02 1996-10-24 Therapeutic benzazepine compounds GR3021440T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919100028A GB9100028D0 (en) 1991-01-02 1991-01-02 Compounds
PCT/GB1991/002326 WO1992011854A1 (en) 1991-01-02 1991-12-30 Therapeutic benzazepine compounds

Publications (1)

Publication Number Publication Date
GR3021440T3 true GR3021440T3 (en) 1997-01-31

Family

ID=10687882

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960402536T GR3021440T3 (en) 1991-01-02 1996-10-24 Therapeutic benzazepine compounds

Country Status (22)

Country Link
US (3) US5254683A (el)
EP (1) EP0517876B1 (el)
JP (1) JP3034604B2 (el)
KR (1) KR100229049B1 (el)
AT (1) ATE144423T1 (el)
AU (1) AU650086B2 (el)
CA (1) CA2058593A1 (el)
CZ (1) CZ299292A3 (el)
DE (1) DE69122858T2 (el)
DK (1) DK0517876T3 (el)
ES (1) ES2093246T3 (el)
FI (1) FI104071B (el)
GB (2) GB9100028D0 (el)
GR (1) GR3021440T3 (el)
HU (2) HU212269B (el)
IE (1) IE920009A1 (el)
IL (1) IL100484A (el)
NO (1) NO300497B1 (el)
NZ (1) NZ241197A (el)
PL (1) PL166481B1 (el)
WO (1) WO1992011854A1 (el)
ZA (1) ZA9223B (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9100028D0 (en) * 1991-01-02 1991-02-20 Ici Plc Compounds
GB9212308D0 (en) * 1992-06-10 1992-07-22 Ici Plc Therapeutic compositions
ATE404201T1 (de) * 1992-06-22 2008-08-15 Univ California Glycinrezeptorantagonisten und ihre verwendung
CA2115792C (en) 1993-03-05 2005-11-01 David J. Mayer Method for the treatment of pain
US5834479A (en) * 1993-03-05 1998-11-10 Mayer; David J. Method and composition for alleviating pain
GB9311948D0 (en) * 1993-06-10 1993-07-28 Zeneca Ltd Substituted nitrogen heterocycles
US5801168A (en) * 1994-06-09 1998-09-01 Zeneca Limited Substituted nitrogen heterocycles
US5476933A (en) * 1994-11-16 1995-12-19 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Azepine synthesis via a diels-alder reaction
FR2796552A1 (fr) 1999-07-21 2001-01-26 Centre Nat Rech Scient Nouvelle utilisation de derives de la beta-naphtoquinone et de leurs sels pour la fabrication de medicaments exercant un effet inhibiteur sur la liberation de glutamate dans le cerveau
JP4989830B2 (ja) * 1999-07-21 2012-08-01 サーントゥル ナシオナル ドゥ ラ ルシェルシュ シャーンティフィク 脳によるグルタミン酸塩の放出に対して抑制効果を示す薬剤を製造するためのベータ−ナフトキノン誘導体の使用
JPWO2016199789A1 (ja) * 2015-06-08 2018-03-29 国立大学法人名古屋大学 トリフルオロメチル置換セミスクアレートの製造方法、トリフルオロメチル置換セミスクアレートを起点とするトリフルオロメチル化合物の製造方法及びトリフルオロメチル基含有化合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1340334A (en) * 1970-07-06 1973-12-12 Rees A H Synthesis of benzazetropolones and hence of kynurenic acids
CY1403A (en) * 1981-08-11 1987-12-18 Ciba Geigy Ag Benzazepin-2-ones
US4410520A (en) * 1981-11-09 1983-10-18 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
US4473575A (en) * 1982-07-19 1984-09-25 Ciba-Geigy Corporation 3-Amino-(1)-benzazepin-2-one-1-alkanoic acids
US4575503A (en) * 1983-02-10 1986-03-11 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
US4477446A (en) * 1983-07-01 1984-10-16 Usv Pharmaceutical Corporation 1-Benzazepines and their pharmaceutical uses
DE3416695A1 (de) * 1984-05-05 1985-11-07 Bayer Ag, 5090 Leverkusen Amidinohydrazone von tetralin-, chromon-, thiochromon- und tretrahydrochinolin-derivaten, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE122009000062I2 (de) * 1989-10-20 2011-01-13 Otsuka Pharma Co Ltd Benzoheterozyklische verbindungen
GB9100028D0 (en) * 1991-01-02 1991-02-20 Ici Plc Compounds
ATE404201T1 (de) * 1992-06-22 2008-08-15 Univ California Glycinrezeptorantagonisten und ihre verwendung

Also Published As

Publication number Publication date
WO1992011854A1 (en) 1992-07-23
US5254683A (en) 1993-10-19
IL100484A (en) 1997-02-18
JPH07502007A (ja) 1995-03-02
EP0517876A1 (en) 1992-12-16
AU9134091A (en) 1992-08-17
NZ241197A (en) 1994-10-26
CZ299292A3 (en) 1993-01-13
FI923759A (fi) 1992-08-20
IL100484A0 (en) 1992-09-06
EP0517876B1 (en) 1996-10-23
CA2058593A1 (en) 1992-07-03
AU650086B2 (en) 1994-06-09
DE69122858T2 (de) 1997-02-20
NO923413D0 (no) 1992-09-01
ATE144423T1 (de) 1996-11-15
JP3034604B2 (ja) 2000-04-17
DK0517876T3 (da) 1997-04-01
HU212269B (en) 1996-07-29
FI104071B1 (fi) 1999-11-15
HU9202618D0 (en) 1992-10-28
ES2093246T3 (es) 1996-12-16
FI104071B (fi) 1999-11-15
HUT64309A (en) 1993-12-28
GB2251616B (en) 1995-01-11
US5446039A (en) 1995-08-29
ZA9223B (en) 1992-09-30
PL295932A1 (en) 1993-10-04
NO300497B1 (no) 1997-06-09
HU211466A9 (en) 1995-11-28
GB9127498D0 (en) 1992-02-19
DE69122858D1 (de) 1996-11-28
NO923413L (no) 1992-09-01
PL166481B1 (en) 1995-05-31
FI923759A0 (fi) 1992-08-20
KR100229049B1 (ko) 1999-11-01
GB2251616A (en) 1992-07-15
US5541319A (en) 1996-07-30
GB9100028D0 (en) 1991-02-20
IE920009A1 (en) 1992-07-15

Similar Documents

Publication Publication Date Title
MY109737A (en) Treatment and compounds.
DE3260529D1 (en) Therapeutically useful 1-alkyl-2-aminotetralin derivatives
MXPA02001571A (es) Metodo de tratamiento para el cancer.
GB2251616B (en) Therapeutic benzazapine compounds
GB9108629D0 (en) Heterocyclic pharmaceutical compounds,preparation and use
IE832680L (en) Nitrosourea derivatives.
MY108455A (en) Therapeutic benzazapine compounds.
PT100641A (pt) Processo de tratamento com benzazepinas, composicoes farmaceuticas que contem estas benzazepinas, compostos benzazepinicos e processo para a sua preparacao
EP0272849A3 (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases
JPS57176910A (en) Medicinal composition